These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 4984385)
1. [Histological lesions in vaccinated mice with nonvirulent strain of Trypanosoma cruzi]. Menezes H Rev Bras Med; 1968 Mar; 25(3):160-5. PubMed ID: 4984385 [No Abstract] [Full Text] [Related]
2. [Histological lesions of the heart in dogs vaccinated with an avirulent strain of Trypanosoma cruzi]. Menezes H Rev Bras Med; 1969 May; 26(5):281-3. PubMed ID: 4994816 [No Abstract] [Full Text] [Related]
3. [Comparative histopathological study of lesions produced by 2 strains of Trypanosoma cruzi]. Andrade SG; Andrade ZA Hospital (Rio J); 1966 Nov; 70(5):1267-78. PubMed ID: 4969516 [No Abstract] [Full Text] [Related]
4. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi. Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704 [TBL] [Abstract][Full Text] [Related]
5. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297 [TBL] [Abstract][Full Text] [Related]
6. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070 [TBL] [Abstract][Full Text] [Related]
7. Histopathology in Rockland mice immunized against American trypanosomiasis (Chagas' disease). Taratuto AL; Yanovsky JF; Schmuñis GA; Traversa OC; González Cappa SM; Parodi AS Am J Trop Med Hyg; 1968 Sep; 17(5):716-23. PubMed ID: 4971018 [No Abstract] [Full Text] [Related]
9. Trypanosoma cruzi: protection of mice with epimastigote antigens from immunologically different parasite strains. González Cappa SM; Pesce UJ; Cantarella AI; Schmuñis GA Exp Parasitol; 1974 Apr; 35(2):179-86. PubMed ID: 4206928 [No Abstract] [Full Text] [Related]
10. [Myocardial cellular damage and the activity of the mitochondrial ATP synthase in rats infected with a Colombian strain of Trypanosoma cruzi]. Rendón DA; Genes CM; Triana O Biomedica; 2007 Jan; 27 Suppl 1():40-9. PubMed ID: 18154244 [TBL] [Abstract][Full Text] [Related]
11. I. The avirulence of the cultivated Y strain of Trypanosoma cruzi. Menezes H Rev Inst Med Trop Sao Paulo; 1970; 12(1):64-8. PubMed ID: 4999679 [No Abstract] [Full Text] [Related]
12. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895 [TBL] [Abstract][Full Text] [Related]
13. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease. Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049 [No Abstract] [Full Text] [Related]
14. Experimental Trypanosoma cruzi myocarditis: relative effects upon the right and left ventricles. Kumar R; Kline IK; Abelmann WH Am J Pathol; 1969 Oct; 57(1):31-48. PubMed ID: 4242332 [No Abstract] [Full Text] [Related]
15. [Triple infection with Paracoccidioides brasiliensis, Trypanosoma cruzi and Histoplasma capsulatum]. Doehnert G; Doehnert HR; Salfelder K Z Tropenmed Parasitol; 1970 Jun; 21(2):201-8. PubMed ID: 4987849 [No Abstract] [Full Text] [Related]
16. DNA damage and nitric oxide synthesis in experimentally infected Balb/c mice with Trypanosoma cruzi. Ribeiro DA; Calvi SA; Picka MM; Persi E; de Carvalho TB; Caetano PK; Nagoshi LR; Lima CR; Machado JM; Salvadori DM Exp Parasitol; 2007 Jul; 116(3):296-301. PubMed ID: 17286971 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038 [TBL] [Abstract][Full Text] [Related]
18. Morphometry of skeletal muscle involvement in mice infected or preimmunized with live attenuated Trypanosoma cruzi. Milei J; Storino RA; Beigelman R; Grana D; Basombrío MA Medicina (B Aires); 1991; 51(6):529-32. PubMed ID: 7476106 [TBL] [Abstract][Full Text] [Related]
19. Lymphoid organ alterations enhanced by sub-lethal doses of coronaviruses in experimentally induced Trypanosoma cruzi infection in mice. Verinaud L; Camargo IJ; Vassallo J; Sakurada JK; Rangel HA Lab Anim Sci; 1999 Feb; 49(1):35-41. PubMed ID: 10090092 [TBL] [Abstract][Full Text] [Related]
20. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]